Skip to content

Karen Lykke Sørensen

Master of Science (Eng.), MBA, b. 1962
  • Member of the Board of Directors of Orion Corporation since 23 March 2022
  • Member of Audit Committee and the R&D Committee
  • Independent of the company and its significant shareholders
  • Ownership of shares 31 Dec 2022: 485 Orion Corporation B shares

Career

2024– Board professional
2018–2024 CEO, Philips Capital, Global
2011–2018 CEO, Philips Nordic
2006–2011 Vice President Western Europe, Sanofi
2001–2006 Vice President, Head of Global Cardiology Business Unit, Sanofi
1999–2001 General Manager Nordic, Biogen

Current key positions of trust

Member of the Board: Orion Corporation 2022–, Biotage 2022–, Vitrolife 2020–

Former key positions of trust

Member of the Board: Oripharm 2018–2019, Meda 2013–2017, Technical university Denmark, SCION 2014–2018, Danish Export Agency, Ministry of Foreign Affairs 2011–2014

Orion_Board_of_Directors_Karen-Lykke-Sorensen.jpg

Member of the Board of Directors

Karen Lykke Sørensen